FDA Inspection 757123 — Statline (Division Of MTF Biologics)

Statline (Division Of MTF Biologics) — FEI 3003447829

The FDA completed an inspection of Statline (Division Of MTF Biologics) on Dec 14, 2011 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 14, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Edison, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.